Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC

Executive Summary

US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.

Advertisement

Related Content

Congress Recommends Public Rulemaking In Puerto Rico: Health & Wellness Industry News Roundup
FTC Homeopathic Disclaimer Policy Should Prompt FDA Changes – Advocacy Group
FTC Homeopathic Advertising Review Spurs Broader Disclaimer Suggestion, Opens New Stage For RCT Debate
Naloxone Switch: Door Opener For Other NDAs That Swing On Consumer Education
Homeopathic Divide: FDA Talks Pre-Market Approval As Industry Floats Label Changes
Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS119521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel